SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stayhealthy.com: Monitoring your wellness on the Web -- Ignore unavailable to you. Want to Upgrade?


To: george eberting who wrote (3746)3/26/2015 5:11:28 AM
From: Coz  Read Replies (1) | Respond to of 3785
 
George, first shares I bought were at a buck thirty. The rest look to be at fifty cents. It would be nice to see the stock go public on good news where we would all make a our wait time sweet. I'm starting to feel a little old though, yet the fingers remain crossed. --Coz



To: george eberting who wrote (3746)5/5/2015 3:00:59 PM
From: rogerover  Read Replies (1) | Respond to of 3785
 
George, to expand on what Coz wrote... the old public Avalon shares were converted to Stayhealthy shares at a price of .25 and a 1:8 ratio, so those of us who once held AVAL in effect paid $2.00/share by not accepting the .25 buyout price. (Many years ago, I realized that Rick McBride -- remember him? -- had the right idea.) If you were here in 1997, you must have had AVAL like Caly, Claudia, Mads and a few others of us.

There was also a Rule 504 offering in 1998 or 1999 where some people purchased shares privately at $2.00/share, which predated the Series A $1.30/share offering that Coz referred to. Series B was also sold at $1.30. Beginning a few years later, when the company was circling the drain after the Amerisource Bergen and Petters debacles, a lot of shares were sold at .25. There might have been some sold at .50 as well, I don't recall.